Jeff Ostrowski • February 14, 2016
China scholar Adam Segal’s latest book delves into the geopolitical and economic implications of cross-border cyberattacks.
Victoria Barbary • February 13, 2016
The agreement of six institutional investors to support a long-term stock benchmark is a sign of the need for a different strategy.
Andrew Barber • February 13, 2016
GDP figures from Japan put BoJ monetary policy under the microscope; Brexit issue on docket at European Council summit.
Daniel Nadler • February 12, 2016
Advances in 3-D technology are changing the way we design and learn from objects — and invest in the companies that make them.
Charles Wallace • February 12, 2016
Online offerings have taken off in the U.K., but the SEC is imposing tighter restrictions on what companies can raise and investors can invest.
Andrew Barber • February 12, 2016
Euro zone ekes out growth in volatile market; ceasefire in Syria stirs skepticism; AIG names Paulson and an Icahn nominee to the board; Dems debate again.
Khadijah M. Silver • February 11, 2016
The fifth and final story in our series on escalating U.S. drug prices looks at the impact that presidential politics will have on the pharma industry.
John Bilton • February 11, 2016
The greenback’s recent travails are a sign of international economic distress rather than U.S. feebleness. A weaker dollar would help.
Andrew Barber • February 11, 2016
Swedish kroner falls on news; British gilts briefly hit all-time low; Societe Generale earnings disappoint; Puerto Rico approves utility restructuring; gold surges.
Gerrard Cowan • February 10, 2016
Inflows into European ETFs hit a record high in 2015 on recovery hopes and attractive valuations.
© 2016 Institutional Investor LLC. All material subject to strictly enforced copyright laws.
Please read our
Term and Conditions and